Good advice Stotes. I will. If you are correct, it means there is sufficient slack in the critical path for the FDA timetable to accommodate the additional Stage 3 work. If so, it means that the process to get to agreement on the endpoints for the validation trial is quite long. As you suggest, I will check with Scott. Cheers.
Good advice Stotes. I will. If you are correct, it means there...
-
- There are more pages in this discussion • 378 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.20 |
Change
-0.040(1.79%) |
Mkt cap ! $187.9M | |||
| Open | High | Low | Value | Volume |
| $2.24 | $2.27 | $2.17 | $41.94K | 18.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 784 | $2.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.28 | 5723 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| EMV (ASX) Chart |